Broad-spectrum Antiviral NV-387 At Phase II Clinical Trial Stage – NV-387 Could Become a Revolutionary Antiviral for Respiratory Viral Infections SHELTON, CONNECTICUT / ACCESS Newswire / September 30, ...

Contraception goes beyond pregnancy prevention—it’s key to protecting sexual health. Barrier methods like condoms and dental ...

Getting a herpes diagnosis can feel like a death knell for your sex life. But, as these women can attest to, that’s not the case at all ...

Cold sores are more prevalent than most people know, but with a combination of anxiety, stigma, and confusion. Most are ...

DelveInsight's DNA Synthesis Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast report includes a ...

A healthy, 15-year-old boy complains of a worsening sore throat that is aggravated by swallowing over the last 2 days. This ...

EG 427 Announces Compelling Initial Topline Clinical Results with EG110A DNA Medicine in Neurogenic Bladder Patients Over 88% reduction in urinary incontinence episodes achieved in low dose cohort at ...

CAN-2409 improved disease-free survival in patients with intermediate-to-high-risk, localized prostate cancer compared to placebo in patients ...

Three Canadian stocks to watch The TSX continues its impressive rally into October, setting fresh record highs and building ...

Detailed price information for Bausch Health Companies Inc (BHC-T) from The Globe and Mail including charting and trades.

Researchers David Chu and Uma Singh have developed and patented a new molecule named POM-L-BHDU. This molecule has shown ...

According to the authors, the study is the first and largest study of this kind to look at long COVID following reinfection ...